Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

‘Capture the Fracture® (CTF) Partnership – Guidance for Policy Shaping’ sets out a step-by-step approach to building secondary fracture prevention policy which can improve patient outcomes, save healthcare costs, and save lives.

The cover page of the new Capture the Fracture guidelines

By 2025 some 500 million people will be living with osteoporosis, a chronic disease which weakens bones and leaves older adults at risk of a fragility fracture - a broken bone which typically occurs after a low-trauma fall. As a result, an estimated 13.5 million fragility fractures will occur worldwide.  

Despite the urgent need to prioritise fragility fracture prevention, there is currently a glaring care gap in which up to 80% of those who have already broken a bone are not being identified and treated with effective therapies. People who have sustained an initial fragility fracture are five times more likely to fracture again, compared to those who have not fractured.  

Professor Cyrus Cooper, IOF President and Professor of Musculoskeletal Science at NDORMS and at the University of Southampton, stated:  “When one fragility fracture occurs, a patient is at imminent risk of sustaining subsequent fractures. Nevertheless, only 20% of fragility fracture patients are currently offered screening or treatment for osteoporosis, the underlying disease. Given the immense and growing burden of fragility fractures, it is clear that health care strategies must be put in place to reduce this unacceptable care gap.” 

The new policy guidance issued by the International Osteoporosis Foundation (IOF) under the framework of the Capture the Fracture® Partnership, makes the case for fracture prevention and shows the clear public health and financial benefits of Post-Fracture Care (PFC) Coordination Programs, also known as Fracture Liaison Services. When widely implemented, such programs represent the most effective strategy to address the fragility fracture crises affecting older populations worldwide.  

Capture the Fracture® Partnership: Guidance for Policy Shaping, available on the Capture the Fracture® website, describes how and why coordinated, multidisciplinary systems of Post-Fracture Care are critical to building an effective policy response. The Guidance outlines the generic components of global, regional and national calls to action, explains the need for Post-Fracture Care program implementation and provides a step-by-step policy guide to help health care authorities and Post-Fracture Care coordinators evaluate their programs in hospitals and health systems worldwide. 

IOF CEO Dr Philippe Halbout added: “This new document shows that there is an overwhelming humanitarian and health economic case to be made for the implementation of secondary fracture prevention strategies, and specifically Post-Fracture Care programs. Osteoporosis-related fractures of the hip and spine in older adults are associated with increased risk of death and long-term disability, more frequent hospital admissions, and loss of independence. This impacts heavily on family caregivers and all too often leads to nursing home admission.” 

Similar stories

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.